Overview: Hemosiderin TestIntroduction: The Hemosiderin Test detects hemosiderin in urine to diagnose hemolytic anemia or iron overload, causing fatigue or dark urine. Aligned with 2023 ASH guidelines, it uses microscopy for high specificity, aiding in hematological screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in clinical pathology for patients with suspected hemolysis or hemochromatosis.
Other Names: Hemosiderin Urine Assay, Iron Overload Test.
FDA Status: Laboratory-developed test (LDT), meeting clinical pathology standards for diagnostic accuracy.
Historical Milestone: Hemosiderin testing began in the 1960s with hemolysis research. Microscopy techniques improved in the 1980s, enhancing diagnostic accuracy.
Purpose: Diagnoses hemolytic anemia or iron overload, guides treatment, and monitors hemosiderin in patients with fatigue or dark urine.
Test Parameters: 1. Hemosiderin
Pretest Condition: No fasting required. Collect urine at any time. Report symptoms like fatigue, dark urine, or jaundice, and list medications.
Specimen: 5-20 mL urine (sterile container). Transport in a biohazard bag within 2 hours.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document fatigue, dark urine, jaundice, or history of hemolytic anemia or iron overload. Include current medications, especially chelators or transfusions.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for anemia or iron overload treatment.
Procedural Considerations: Uses microscopy to detect hemosiderin in urine. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Hematuria, improper storage, or recent transfusions can affect results. Low hemosiderin levels may yield false negatives.
Clinical Significance: Presence of hemosiderin suggests hemolytic anemia or iron overload, prompting treatment. Negative results may require further testing.
Specialist Consultation: Consult a hematologist for result interpretation and management planning.
Additional Supporting Tests: Ferritin, TIBC, haptoglobin, or liver function tests to confirm hemolytic anemia or iron overload.
Test Limitations: Non-specific hemosiderin detection may occur in hematuria. Clinical correlation is needed.
References: ASH Hemolytic Anemia Guidelines, 2023; Blood, Schrier SL, 2022.
